Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HYALURONIDASE-OCSQ\OCRELIZUMAB: 171 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
171
Total FAERS Reports
0
Deaths Reported
7
Hospitalizations
171
As Primary/Secondary Suspect

First Report: 20220101 · Latest Report: 20250919

What Are the Most Common HYALURONIDASE-OCSQ\OCRELIZUMAB Side Effects?

#1 Most Reported
Injection site erythema
23 reports (13.5%)
#2 Most Reported
Off label use
21 reports (12.3%)
#3 Most Reported
Injection site pain
20 reports (11.7%)

All HYALURONIDASE-OCSQ\OCRELIZUMAB Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Injection site erythema 23 13.5% 0 2
Off label use 21 12.3% 0 1
Injection site pain 20 11.7% 0 2
Contusion 17 9.9% 0 1
Fatigue 17 9.9% 0 0
No adverse event 13 7.6% 0 0
Pain 13 7.6% 0 0
Erythema 12 7.0% 0 0
Injection site reaction 12 7.0% 0 0
Headache 10 5.9% 0 0
Injection site swelling 10 5.9% 0 2
Rash 10 5.9% 0 0
Swelling 8 4.7% 0 0
Pain in extremity 7 4.1% 0 0
Multiple sclerosis relapse 6 3.5% 0 1
Abdominal pain 5 2.9% 0 1
Asthenia 5 2.9% 0 0
Diarrhoea 5 2.9% 0 0
Gait disturbance 5 2.9% 0 1
Injection site pruritus 5 2.9% 0 0

Who Reports HYALURONIDASE-OCSQ\OCRELIZUMAB Side Effects? Age & Gender Data

Gender: 73.8% female, 26.2% male. Average age: 45.4 years. Most reports from: US. View detailed demographics →

Is HYALURONIDASE-OCSQ\OCRELIZUMAB Getting Safer? Reports by Year

YearReportsDeathsHosp.
2022 1 0 0
2023 1 0 1
2024 15 0 2
2025 54 0 1

View full timeline →

What Is HYALURONIDASE-OCSQ\OCRELIZUMAB Used For?

IndicationReports
Multiple sclerosis 65
Product used for unknown indication 41
Relapsing multiple sclerosis 32
Relapsing-remitting multiple sclerosis 20
Primary progressive multiple sclerosis 14

HYALURONIDASE-OCSQ\OCRELIZUMAB vs Alternatives: Which Is Safer?

HYALURONIDASE-OCSQ\OCRELIZUMAB vs HYALURONIDASE \RITUXIMAB HYALURONIDASE-OCSQ\OCRELIZUMAB vs HYALURONIDASE-ZZXF\PERTUZUMAB\TRASTUZUMAB HYALURONIDASE-OCSQ\OCRELIZUMAB vs HYDRALAZINE HYALURONIDASE-OCSQ\OCRELIZUMAB vs HYDRALAZINE\ISOSORBIDE DINITRATE HYALURONIDASE-OCSQ\OCRELIZUMAB vs HYDROCHLOROTHIAZIDE HYALURONIDASE-OCSQ\OCRELIZUMAB vs HYDROCHLOROTHIAZIDE\IRBESARTAN HYALURONIDASE-OCSQ\OCRELIZUMAB vs HYDROCHLOROTHIAZIDE\LISINOPRIL HYALURONIDASE-OCSQ\OCRELIZUMAB vs HYDROCHLOROTHIAZIDE\LOSARTAN HYALURONIDASE-OCSQ\OCRELIZUMAB vs HYDROCHLOROTHIAZIDE\METOPROLOL HYALURONIDASE-OCSQ\OCRELIZUMAB vs HYDROCHLOROTHIAZIDE\NEBIVOLOL

Official FDA Label for HYALURONIDASE-OCSQ\OCRELIZUMAB

Official prescribing information from the FDA-approved drug label.